Skip to content
TORPEDO is a cluster-randomised controlled trial of an Australian primary healthcare quality improvement (QI) intervention (HealthTracker-CVD). The trial aims to address barriers to improved cardiovascular disease risk management and prevention. The intervention comprises computerised decision support, audit and feedback tools, and clinical workforce training.
The TORPEDO study is taking place in 40 general practices and 20 Aboriginal Community Controlled Health Services in NSW and Queensland.
The Health tracker tool is an electronic decision support system which allows health professionals to implement recommendations from proven clinical guidelines. Health tracker-CVD is the first tool to be developed in a series of chronic disease tools. It assesses cardiovascular risk and provides treatment advice in a clear way so that patients can understand their risks and see what actions they should be taking.
Abstract adapted from the George Institute for Global Health
Associate Professor David Peiris
The George Institute for Global Health
Level 13, 321 Kent Street
Sydney NSW 2000
Ph: (02) 9993 4513
Ph: (02) 9657 0300
Fax: (02) 9657 0301